PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-04-23

Date Title Company
23-Apr-2020 Global Mycophenolate Mofetil Market Trends That Will Drive Success in 2020 | Genentech, Teva, Sandoz Wired Release
23-Apr-2020 Global Mycophenolate Mofetil Market Trends That Will Drive Success in 2020 | Genentech, Teva, Sandoz Wired Release
23-Apr-2020 Global Multiple Myeloma Drugs Market Trends That Will Drive Success in 2020 | Amgen, Johnson & Johnson, Celgene Wired Release
23-Apr-2020 Global Multiple Myeloma Drugs Market Trends That Will Drive Success in 2020 | Amgen, Johnson & Johnson, Celgene Wired Release
23-Apr-2020 Brits trust doctors and pharma industry, but not each other Thornton & Ross
23-Apr-2020 MEDICLIN publishes preliminary figures for the first quarter of 2020 and, due to the Corona pan-demic, lowers its forecast for 2020 MediClin AG
23-Apr-2020 Thermo Fisher Scientific Launches CE/IVD Marked Immunosuppressants Panel for the Cascadion SM Clinical Analyzer Thermo Fisher Scientific
23-Apr-2020 ReiThera, LEUKOCARE and Univercells Announce Pan-European Consortium for the Fast-track Development of a Single-dose Adenovirus-based COVID-19 Vaccine ReiThera; Univercells; LEUKOCARE
23-Apr-2020 Noscendo Closes Series A Financing and Launches DISQVER® in Europe to Significantly Improve Diagnosis of Infectious Diseases B3C newswire
23-Apr-2020 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020 Heidelberg Pharma AG
23-Apr-2020 New Early Breast Cancer Drug Available Now In Singapore Specialised Therapeutics Asia
23-Apr-2020 Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs Bugworks Research Inc.
23-Apr-2020 Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs Bugworks Research Inc.
23-Apr-2020 Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs Bugworks Research Inc.
23-Apr-2020 Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody) Samsung Biologics